These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2419769)

  • 21. Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats.
    Penit-Soria J; Durand C; Herve D; Besson MJ
    Neuroscience; 1997 Apr; 77(3):753-66. PubMed ID: 9070750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-cholinergic action of exogenous acetylcholinesterase in the rat substantia nigra. II. Long-term interactions with dopamine metabolism.
    Hawkins CA; Greenfield SA
    Behav Brain Res; 1992 Jun; 48(2):159-63. PubMed ID: 1616606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid behavioural and biochemical effects of tetanus toxin microinjected into the substantia nigra: a dual role for GABA?
    James TA; Collingridge GL
    Neurosci Lett; 1979 Feb; 11(2):205-8. PubMed ID: 460688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
    Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of the nigro-striatal dopaminergic system during precipitated morphine withdrawal investigated in rats with acute unilateral inactivation of the striatum.
    Laschka E; Herz A; Bläsig J
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):15-23. PubMed ID: 1034882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area.
    Bradbury AJ; Costall B; Jenner PG; Kelly ME; Marsden CD; Naylor RJ
    Neuropharmacology; 1986 Aug; 25(8):939-41. PubMed ID: 3774119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric dopamine and serotonin metabolism in nigrostriatal and limbic structures of the trained circling rat.
    Yamamoto BK; Freed CR
    Brain Res; 1984 Apr; 297(1):115-9. PubMed ID: 6202362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DTG-induced circling behaviour in rats may involve the interaction between sigma sites and nigro-striatal dopaminergic pathways.
    Bastianetto S; Rouquier L; Perrault G; Sanger DJ
    Neuropharmacology; 1995 Mar; 34(3):281-7. PubMed ID: 7630482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the nigrostriatal dopaminergic pathway by injection of cholera enterotoxin into the substantia nigra.
    Quenzer LF; Galli CL; Neff NH
    Science; 1977 Jan; 195(4273):78-80. PubMed ID: 831258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
    Rioux L; Gaudin DP; Gagnon C; Di Paolo T; Bédard PJ
    Neuroscience; 1991; 44(1):75-83. PubMed ID: 1770999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
    Tan DP; Tsou K
    J Neurochem; 1988 Nov; 51(5):1333-7. PubMed ID: 2459306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of pyrethroid insecticides on extracellular dopamine in the striatum of freely moving rats.
    Mubarak Hossain M; Suzuki T; Sato N; Sato I; Takewaki T; Suzuki K; Tachikawa E; Kobayashi H
    Toxicol Appl Pharmacol; 2006 Nov; 217(1):25-34. PubMed ID: 16956637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the participation of nigrotectal gamma-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat.
    Kilpatrick IC; Collingridge GL; Starr MS
    Neuroscience; 1982 Jan; 7(1):207-22. PubMed ID: 7078726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.
    Elsworth JD; Deutch AY; Redmond DE; Sladek JR; Roth RH
    Brain Res; 1987 Jul; 415(2):293-9. PubMed ID: 3496938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
    Andrews JS; Sahgal A
    Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Konieczny J; Lenda T; Czarnecka A
    Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo dopaminergic activity from nucleus accumbens, substantia nigra and ventral tegmental area in the freely moving rat: basal neurochemical output and prolactin effect.
    Chen JC; Ramirez VD
    Neuroendocrinology; 1988 Oct; 48(4):329-35. PubMed ID: 2463493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta.
    Kamata K; Kameyama T; Okuyama S; Hashimoto S; Aihara H
    Brain Res; 1986 Mar; 367(1-2):1-7. PubMed ID: 3008917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
    J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.